Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity
Identifieur interne : 000679 ( Main/Exploration ); précédent : 000678; suivant : 000680Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity
Auteurs : Kelly M. Lohr [États-Unis] ; Kristen A. Stout [États-Unis] ; Amy R. Dunn [États-Unis] ; Minzheng Wang [États-Unis] ; Ali Salahpour [Canada] ; Thomas S. Guillot [États-Unis] ; Gary W. Miller [États-Unis]Source :
- ACS chemical neuroscience [ 1948-7193 ] ; 2015.
Abstract
The psychostimulant methamphetamine (METH) is highly addictive and neurotoxic to dopamine terminals. METH toxicity has been suggested to be due to the release and accumulation of dopamine in the cytosol of these terminals. The vesicular monoamine transporter 2 (VMAT2;
Url:
DOI: 10.1021/acschemneuro.5b00010
PubMed: 25746685
PubMed Central: 4489556
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000763
- to stream Pmc, to step Curation: 000763
- to stream Pmc, to step Checkpoint: 000281
- to stream Ncbi, to step Merge: 001A84
- to stream Ncbi, to step Curation: 001A84
- to stream Ncbi, to step Checkpoint: 001A84
- to stream Main, to step Merge: 000680
- to stream Main, to step Curation: 000679
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity</title>
<author><name sortKey="Lohr, Kelly M" sort="Lohr, Kelly M" uniqKey="Lohr K" first="Kelly M." last="Lohr">Kelly M. Lohr</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Stout, Kristen A" sort="Stout, Kristen A" uniqKey="Stout K" first="Kristen A." last="Stout">Kristen A. Stout</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dunn, Amy R" sort="Dunn, Amy R" uniqKey="Dunn A" first="Amy R." last="Dunn">Amy R. Dunn</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wang, Minzheng" sort="Wang, Minzheng" uniqKey="Wang M" first="Minzheng" last="Wang">Minzheng Wang</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Salahpour, Ali" sort="Salahpour, Ali" uniqKey="Salahpour A" first="Ali" last="Salahpour">Ali Salahpour</name>
<affiliation wicri:level="4"><nlm:aff id="A5">Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Guillot, Thomas S" sort="Guillot, Thomas S" uniqKey="Guillot T" first="Thomas S." last="Guillot">Thomas S. Guillot</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Miller, Gary W" sort="Miller, Gary W" uniqKey="Miller G" first="Gary W." last="Miller">Gary W. Miller</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="A2">Center for Neurodegenerative Diseases, Emory University, Atlanta, Georgia 30322, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Neurodegenerative Diseases, Emory University, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="A3">Department of Pharmacology, Emory University, Atlanta, Georgia 30322, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pharmacology, Emory University, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="A4">Department of Neurology, Emory University, Atlanta, Georgia 30322, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Emory University, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">25746685</idno>
<idno type="pmc">4489556</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489556</idno>
<idno type="RBID">PMC:4489556</idno>
<idno type="doi">10.1021/acschemneuro.5b00010</idno>
<date when="2015">2015</date>
<idno type="wicri:Area/Pmc/Corpus">000763</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000763</idno>
<idno type="wicri:Area/Pmc/Curation">000763</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000763</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000281</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000281</idno>
<idno type="wicri:Area/Ncbi/Merge">001A84</idno>
<idno type="wicri:Area/Ncbi/Curation">001A84</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001A84</idno>
<idno type="wicri:Area/Main/Merge">000680</idno>
<idno type="wicri:Area/Main/Curation">000679</idno>
<idno type="wicri:Area/Main/Exploration">000679</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity</title>
<author><name sortKey="Lohr, Kelly M" sort="Lohr, Kelly M" uniqKey="Lohr K" first="Kelly M." last="Lohr">Kelly M. Lohr</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Stout, Kristen A" sort="Stout, Kristen A" uniqKey="Stout K" first="Kristen A." last="Stout">Kristen A. Stout</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Dunn, Amy R" sort="Dunn, Amy R" uniqKey="Dunn A" first="Amy R." last="Dunn">Amy R. Dunn</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wang, Minzheng" sort="Wang, Minzheng" uniqKey="Wang M" first="Minzheng" last="Wang">Minzheng Wang</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Salahpour, Ali" sort="Salahpour, Ali" uniqKey="Salahpour A" first="Ali" last="Salahpour">Ali Salahpour</name>
<affiliation wicri:level="4"><nlm:aff id="A5">Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario M5S 1A8</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Guillot, Thomas S" sort="Guillot, Thomas S" uniqKey="Guillot T" first="Thomas S." last="Guillot">Thomas S. Guillot</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Miller, Gary W" sort="Miller, Gary W" uniqKey="Miller G" first="Gary W." last="Miller">Gary W. Miller</name>
<affiliation wicri:level="1"><nlm:aff id="A1">Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="A2">Center for Neurodegenerative Diseases, Emory University, Atlanta, Georgia 30322, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Center for Neurodegenerative Diseases, Emory University, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="A3">Department of Pharmacology, Emory University, Atlanta, Georgia 30322, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pharmacology, Emory University, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="A4">Department of Neurology, Emory University, Atlanta, Georgia 30322, United States</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Emory University, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">ACS chemical neuroscience</title>
<idno type="eISSN">1948-7193</idno>
<imprint><date when="2015">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p id="P1">The psychostimulant methamphetamine (METH) is highly addictive and neurotoxic to dopamine terminals. METH toxicity has been suggested to be due to the release and accumulation of dopamine in the cytosol of these terminals. The vesicular monoamine transporter 2 (VMAT2; <italic>SLC18A2</italic>
) is a critical mediator of dopamine handling. Mice overexpressing VMAT2 (VMAT2-HI) have an increased vesicular capacity to store dopamine, thus augmenting striatal dopamine levels and dopamine release in the striatum. Based on the altered compartmentalization of intracellular dopamine in the VMAT2-HI mice, we assessed whether enhanced vesicular function was capable of reducing METH-induced damage to the striatal dopamine system. While wildtype mice show significant losses in striatal levels of the dopamine transporter (65% loss) and tyrosine hydroxylase (46% loss) following a 4 × 10 mg/kg METH dosing regimen, VMAT2-HI mice were protected from this damage. VMAT2-HI mice were also spared from the inflammatory response that follows METH treatment, showing an increase in astroglial markers that was approximately one-third of that of wildtype animals (117% vs 36% increase in GFAP, wildtype vs VMAT2-HI). Further analysis also showed that elevated VMAT2 level does not alter the ability of METH to increase core body temperature, a mechanism integral to the toxicity of the drug. Finally, the VMAT2-HI mice showed no difference from wildtype littermates on both METH-induced conditioned place preference and in METH-induced locomotor activity (1 mg/kg METH). These results demonstrate that elevated VMAT2 protects against METH toxicity without enhancing the rewarding effects of the drug. Since the VMAT2-HI mice are protected from METH despite higher basal dopamine levels, this study suggests that METH toxicity depends more on the proper compartmentalization of synaptic dopamine than on the absolute amount of dopamine in the brain.</p>
<p id="P2"><graphic xlink:href="nihms696525u1.jpg" position="float" orientation="portrait"></graphic>
</p>
</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
<li>États-Unis</li>
</country>
<region><li>Ontario</li>
</region>
<settlement><li>Toronto</li>
</settlement>
<orgName><li>Université de Toronto</li>
</orgName>
</list>
<tree><country name="États-Unis"><noRegion><name sortKey="Lohr, Kelly M" sort="Lohr, Kelly M" uniqKey="Lohr K" first="Kelly M." last="Lohr">Kelly M. Lohr</name>
</noRegion>
<name sortKey="Dunn, Amy R" sort="Dunn, Amy R" uniqKey="Dunn A" first="Amy R." last="Dunn">Amy R. Dunn</name>
<name sortKey="Guillot, Thomas S" sort="Guillot, Thomas S" uniqKey="Guillot T" first="Thomas S." last="Guillot">Thomas S. Guillot</name>
<name sortKey="Miller, Gary W" sort="Miller, Gary W" uniqKey="Miller G" first="Gary W." last="Miller">Gary W. Miller</name>
<name sortKey="Miller, Gary W" sort="Miller, Gary W" uniqKey="Miller G" first="Gary W." last="Miller">Gary W. Miller</name>
<name sortKey="Miller, Gary W" sort="Miller, Gary W" uniqKey="Miller G" first="Gary W." last="Miller">Gary W. Miller</name>
<name sortKey="Miller, Gary W" sort="Miller, Gary W" uniqKey="Miller G" first="Gary W." last="Miller">Gary W. Miller</name>
<name sortKey="Stout, Kristen A" sort="Stout, Kristen A" uniqKey="Stout K" first="Kristen A." last="Stout">Kristen A. Stout</name>
<name sortKey="Wang, Minzheng" sort="Wang, Minzheng" uniqKey="Wang M" first="Minzheng" last="Wang">Minzheng Wang</name>
</country>
<country name="Canada"><region name="Ontario"><name sortKey="Salahpour, Ali" sort="Salahpour, Ali" uniqKey="Salahpour A" first="Ali" last="Salahpour">Ali Salahpour</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000679 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000679 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Main |étape= Exploration |type= RBID |clé= PMC:4489556 |texte= Increased Vesicular Monoamine Transporter 2 (VMAT2; Slc18a2) Protects against Methamphetamine Toxicity }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25746685" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonCanadaV1
This area was generated with Dilib version V0.6.29. |